Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105512877 | 10551287 | 7 | F | 201510 | 20160811 | 20141029 | 20160818 | EXP | PHHY2014BR140438 | NOVARTIS | 48.18 | YR | F | Y | 59.00000 | KG | 20160818 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105512877 | 10551287 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, QMO, EVERY 28 DAYS | 21008 | 30 | MG | /month | |||||||
| 105512877 | 10551287 | 2 | C | CALCIUM BICARBONATE | CALCIUM BICARBONATE | 1 | Unknown | 6 DF, QD | Y | 0 | 6 | DF | TABLET | QD | |||||
| 105512877 | 10551287 | 3 | C | CALCIUM BICARBONATE | CALCIUM BICARBONATE | 1 | Unknown | 1 DF, QD | Y | 0 | 1 | DF | TABLET | QD | |||||
| 105512877 | 10551287 | 4 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Unknown | 2 DF, QD | 0 | 2 | DF | TABLET | QD | ||||||
| 105512877 | 10551287 | 5 | C | NORTRIPTYLINE | NORTRIPTYLINE | 1 | Unknown | 1 DF, QD | 0 | 1 | DF | TABLET | QD | ||||||
| 105512877 | 10551287 | 6 | C | CALCITRIOL. | CALCITRIOL | 1 | Unknown | 2 DF, QD | Y | 0 | 2 | DF | TABLET | QD | |||||
| 105512877 | 10551287 | 7 | C | CALCITRIOL. | CALCITRIOL | 1 | Unknown | 1 DF, QD | Y | 0 | 1 | DF | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 105512877 | 10551287 | 1 | Neuroendocrine tumour |
| 105512877 | 10551287 | 2 | Osteoporosis |
| 105512877 | 10551287 | 4 | Hyperchlorhydria |
| 105512877 | 10551287 | 5 | Product used for unknown indication |
| 105512877 | 10551287 | 6 | Osteoporosis |
| 105512877 | 10551287 | 7 | Hypothyroidism |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 105512877 | 10551287 | OT |
| 105512877 | 10551287 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 105512877 | 10551287 | Abdominal pain | |
| 105512877 | 10551287 | Asthenia | |
| 105512877 | 10551287 | Back pain | |
| 105512877 | 10551287 | Breast cancer | |
| 105512877 | 10551287 | Breast induration | |
| 105512877 | 10551287 | Breast pain | |
| 105512877 | 10551287 | Dysentery | |
| 105512877 | 10551287 | Hepatic neoplasm | |
| 105512877 | 10551287 | Nephrolithiasis | |
| 105512877 | 10551287 | Pain | |
| 105512877 | 10551287 | Pancreatic neoplasm | |
| 105512877 | 10551287 | Parathyroid disorder | |
| 105512877 | 10551287 | Second primary malignancy | |
| 105512877 | 10551287 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 105512877 | 10551287 | 1 | 2007 | 0 | ||
| 105512877 | 10551287 | 2 | 2006 | 0 | ||
| 105512877 | 10551287 | 4 | 2006 | 0 | ||
| 105512877 | 10551287 | 5 | 2006 | 0 | ||
| 105512877 | 10551287 | 6 | 2006 | 0 |